1. Nanomedicine: A Historical Perspective
William Etheridge, Badri Parshad, Ishtiaq Ahmed, Cristina Gonzalez-Lopez, and Ljiljana Fruk
2. Clinically Approved Nanotherapeutics
Susana I.C.J. Palma
3. High-Priority Pathogens: Where Do We Stand?
Raquel Portela, Klementina Borovnik, Constança M.P. Costa, Inês R. Grilo, and Pedro M. Pereira
4. Overview of Nanotherapeutics for Viral Infections
Valeria Nele
5. Formulation Approaches for COVID-19 Vaccines
Mohammed M. Al Qaraghuli, Mohammad A. Obeid, Ahmed A. Abdulhussein Al-Ali, Judith Kuntsche, Carsten Uhd Nielsen, and Paul A. Mulheran
6. Overview of Nanotherapeutics for Bacterial Infections
José Muñoz-López, Cátia D.F. Lopes, and Íris Luz Batalha
7. Nanotechnology Applied to Tackle Malaria
Yunuen Avalos-Padilla and Xavier Fernàndez-Busquets
8. Overview of Nanotherapeutics for Fungal Infections
Filipa Sousa, Domingos Ferreira, Salette Reis, and Paulo Costa
9. Biogenic and Biomimetic Nanocarriers
Chenwen Li, Chunfan Zhang, Gang Li, and Jianxiang Zhang
Biography
Íris Luz Batalha is currently a junior leader research fellow at the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, a course director in nanotherapeutics at the University of Cambridge Institute of Continuing Education, a freelance senior innovation strategy consultant, a co-founder and director of the non-profit organization Women Ahead of Their Time (WATT), and a research associate at Peterhouse College. From 2017 to 2020, she was a joint research associate at the Department of Engineering Nanoscience Centre and Department of Medicine Molecular Immunity Unit, University of Cambridge. From 2014 to 2017, she worked at the Department of Chemical Engineering and Biotechnology, University of Cambridge, and the biopharmaceutical company MedImmune/AstraZeneca, followed by a brief experience as a healthcare/pharmaceutical competitive intelligence consultant. Her research interests and expertise lie in medical and pharmaceutical research and development, particularly in the fields of nanobiotechnology, bioinspired materials, downstream processing, formulation, and drug delivery.
“This insightful compendium summarizes the fundamentals of nanomedicine-based drug delivery, and it showcases current and future strategies on the use of advanced nanotherapeutics for the treatment of viral, bacterial, and fungal infections.”
Prof. Twan Lammers; RWTH Aachen University Clinic, Germany
“This book is an educational collection of exciting advancements in nanotechnology that have the potential to transform the ways infections are treated, an important health issue affecting many people. This valuable resource connects innovative science with real-world applications, making it accessible for everyone interested in better healthcare solutions.”
Prof. Bruno Sarmento; University of Porto, Portugal
“This book offers an insightful, timely exploration of cutting-edge nanotechnology applications in combating infectious diseases, from bacterial to viral pathogens, and is a valuable resource for researchers, clinicians, and policymakers striving to address global health challenges through innovative therapeutic strategies.”
Prof. María J. Vicent; Centro Investigación Príncipe Felipe (CIPF), Spain
“This book is a must-read for anyone interested in the therapeutic development of nanoparticles for infectious disease. It combines scholarly rigor, scientific insights, and a comprehensive analysis of the state of the art and provides an incredibly useful roadmap for anyone wishing to create novel nanotherapeutics.”
Prof. Andres Floto; Victor Phillip Dahdaleh Heart and Lung Research Institute, UK
“This invaluable and timely book brings together perspectives on how the nanotherapeutics field has developed, the myriad of treatment opportunities it offers, and an insight into future opportunities and challenges. As such, it is an invaluable resource for nanoscientists and medical practitioners alike.”
Prof. Sir Mark Welland, FRS, FREng; University of Cambridge, UK
